For the sake of consistency and fairness: why insurance companies should cover fertility preservation treatment for iatrogenic infertility.
Campo-Engelstein
Lisa
L
Oncofertility Consortium and Center for Bioethics, Science & Society, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. ltce@northwestern.edu
D006801:Humans; D007049:Iatrogenic Disease / Q000191:economics / Q000517:prevention & control*; D007246:Infertility / Q000191:economics / Q000517:prevention & control*; D019458:Insurance Coverage / Q000458:organization & administration*; D027724:Reproductive Techniques, Assisted / Q000191:economics*; D014021:Tissue Preservation / Q000191:economics*
Science. 2007 Apr 20;316(5823):388-9
17446383
Eplasty. 2009 Jun 02;9:e18
19572009
Bioethics. 2009 Jan;23(1):47-58
19076941
Hastings Cent Rep. 1998 May-Jun;28(3):24-35
9669179
Harv Law Rev. 1996 Jun;109(8):2092-2109
10160574
J Clin Oncol. 2006 Jun 20;24(18):2917-31
16651642